Revolutionising prenatal diagnosis
Maternal blood foetal DNA test to detect chromosomal abnormalities associated with Down's, Edwards' or Patau syndromes. By using Next-Generation Sequencing (NGS) and applying the NIFTY® algorithm, this test estimates the risk of presenting these diseases with a reliability of more than 99%. It also provides information about other genetic alterations and the sex of the foetus.
At NIMGenetics we are committed to quality in all our processes. We have obtained the ENAC - ISO 15189 accreditation for foetal aneuploidy screening (chromosomes 13, 18, 21, X and Y), as well as for maternal blood foetal sex determination through massive parallel sequencing (NGS). Our management system is also certified by Bureau Veritas, in accordance with the requirements of the ISO 9001:2015 Standard, for providing diagnostic genetic testing services in pre-analytical, analytical and post-analytical stages for the specialities of genomics, non-invasive prenatal testing and molecular diagnostics.
More info at [ Ссылка ]
